Related Experiment Video
Updated: Jan 29, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species
Luana Rossato1, Erico S Loreto1,2, Tarcieli P Venturini1
1Postgraduate Program in Pharmaceutical Sciences, Health Sciences Centre, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil.
Abstract:
Cryptococcus species are an encapsulated fungal pathogen that cause cryptococcal meningitis. There are limited therapeutic options for this infection. The management includes the use of different antifungals such as amphotericin B, flucytosine, or fluconazole, either alone or in combination. However, numerous therapeutic failures, as well as the limited effectiveness of such therapeutics, have been described. Diphenyl diselenide is a chemically synthesised molecule with was found to have antimicrobial activity. In this study, we evaluated the antifungal activities of fluconazole, amphotericin B and flucytosine, in combination with diphenyl diselenide against 30 clinical isolates of Cryptococcus spp. using CLSI M27-A3 method and the checkerboard microdilution technique. Our results show that the combination of flucytosine and diphenyl diselenide displayed 100% of synergism. However, when we analysed (PhSe)2 plus AMB or FLZ we observed around 70% of indifference. Our results suggest that the combination of diphenyl diselenide with other antifungal agents deserves attention as a new option for the development of alternative therapies for cryptococcosis.
Insights
Diphenyl diselenide combined with flucytosine shows 100% synergy against Cryptococcus species, offering a promising new avenue for treating cryptococcal meningitis. This combination therapy warrants further investigation for improved antifungal treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Cryptococcus species are significant fungal pathogens causing cryptococcal meningitis, a serious infection with limited therapeutic options.
- Current antifungal treatments like amphotericin B, flucytosine, and fluconazole have documented therapeutic failures and limited effectiveness.
- Diphenyl diselenide is a synthetic molecule demonstrating known antimicrobial properties.
Purpose of the Study:
- To evaluate the combined antifungal activity of diphenyl diselenide with established antifungals (fluconazole, amphotericin B, flucytosine) against clinical isolates of Cryptococcus spp.
- To identify synergistic or indifferent interactions between diphenyl diselenide and standard antifungal agents.
Main Methods:
- Utilized the CLSI M27-A3 standard method for antifungal susceptibility testing.
- Employed the checkerboard microdilution technique to assess drug combinations.
- Tested against 30 clinical isolates of Cryptococcus species.
Main Results:
- The combination of diphenyl diselenide and flucytosine demonstrated 100% synergism against all tested Cryptococcus isolates.
- Combinations of diphenyl diselenide with amphotericin B or fluconazole showed approximately 70% indifference.
Conclusions:
- Diphenyl diselenide exhibits significant synergistic activity when combined with flucytosine against Cryptococcus species.
- This synergistic interaction suggests that diphenyl diselenide holds potential as a component in novel combination therapies for cryptococcosis.
- Further research into diphenyl diselenide-based antifungal combinations is recommended for developing alternative treatments.
Related Concept Videos
What is a Species?
Keystone Species
Formation of Species
Multi-species Conserved Sequences
Although the genome of each species varies greatly from each other, a few sequences are highly conserved. Such conserved...
Impedance Combination
Combination Of Resistors

